Research/art/teacher profile of a person
Name and surname:
Mgr. Lucia Lintnerová, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Lintnerová
I.2 - Name
Lucia
I.3 - Degrees
Mgr., PhD.
I.4 - Year of birth
1984
I.5 - Name of the workplace
Department of chemical theory of drugs. Faculty of Pharmacy, Comenius Unierzity in Bratislava
I.6 - Address of the workplace
Kalinčiakova street no.8, 34104, Bratislava, Slovakia
I.7 - Position
assistant professor
I.8 - E-mail address
lintnerova4@uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/20117?mode=full&do=filterForm-submit&name=Lucia&surname=Lintnerov%C3%A1&sort=surname&employment_state=yes&filter=Vyh%C4%BEada%C5%A5
I.10 - Name of the study field in which a person works at the university
pharmacy
I.11 - ORCID iD
0000-0003-1442-9951

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.a - Name of the university or institution
Faculty of Natural Sciences, Comenius Univerzity in Bratislava
II.b - Year
2003
II.c - Study field and programme
chemistry
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of Natural Sciences, Comenius Univerzity in Bratislava
II.b - Year
2006
II.c - Study field and programme
bioorganic chemistry
II.3 - Third degree of higher education
II.a - Name of the university or institution
Faculty of Natural Sciences, Comenius Univerzity in Bratislava
II.b - Year
2008
II.c - Study field and programme
organic chemistry
II.4 - Associate professor
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
assistant professor Faculty of Pharmacy, Comenius University in Bratislava 2013 - until now

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
Protection of animals used for scientific purposes and educational purposes (module: performing of procedures and projects) Institute of postgraduate education of veterinary surgeons 2015
Comenius University Science Park Comenius Univerzity in Bratislava 2014-2015

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.2.a - Name of the study programme V.2.b - Degree V.2.c - Field of study
Pharmacy master Pharmacy
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.b - Diploma (second degree)
4
V.4.2 - Number of defended theses
V.4.b - Diploma (second degree)
20
V.5 - Overview of other courses taught in the current academic year according to study programmes
V.5.a - Name of the course V.5.b - Study programme V.5.c - Degree V.5.d - Field of study
General and Inorganic Chemistry Pharmacy master Pharmacy
Organic chemistry 1 Pharmacy master Pharmacy
Principles of Molecular Modeling Pharmacy master Pharmacy
Bioorganic chemistry Pharmacy master Pharmacy

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
37
VI.1.b - Over the last six years
13
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
8
VI.1.b - Over the last six years
3
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
86
VI.1.b - Over the last six years
61
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
63
VI.1.b - Over the last six years
54
VI.1.5 - Number of invited lectures at the international, national level
VI.2 - The most significant research/artistic/other outputs
1

A development of chimeric VEGFR2 TK inhibitor based on two ligand conformers from PDB: 1Y6A complex - Medicinal chemistry consequences of a TKs analysis

Authors: Lintnerova, L Garcia-Caballero, M, Gregan, FMelichercik, MQuesada, ARDobias, JLac, J, Salisova, MBohac, A 

Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Volume: 72

Page: 146-159

DOI: 10.1016/j.ejmech.2013.11.023

Published: 2014

2

Chiral ligand induced geometrical type of isomerism in Schiff-base Copper (II) complexes with urease inhibitory activities

Authors: Valentová, J., Lintnerová, L., Sláviková, B., Baran, P.

Journal: Inorganica Chimica Acta

Volume: 558

paged: 1-8

article number: 121707 [online]

DOI: 10.1016/j.ica.2023.121707

Published: 2023

3

Analogues of Anticancer Natural Products: Chiral Aspects

Authors: Valentová, J., Lintnerová, L., Miklášová, N., Oboňová, B., Habala, L.

Journal: International journal of molecular sciences [elektronický dokument]

Volume: 24

Issue: 6

Pages: 1-23

article number: 5679 [online]

DOI: 10.3390/ijms24065679

Published: 2023

4

Synthesis and antiradical activity of novel copper(II) complexes of long chain reduced Schiff base ligands

Authors: Lintnerova, LValentova, JHerich, P, Kozisek, J, Devinsky, F,

Journal: MONATSHEFTE FUR CHEMIE

Volume: 149

Issue: 5

Page: 901-911

DOI: 10.1007/s00706-017-2137-z

Published: 2018

5

Selected Methodologies Convenient for the Synthesis of N,5-Diaryloxazole-2-amine Pharmacophore

Authors: Lintnerova, LKovacikova, L, Hanquet, G, Bohac, A

 Journal: JOURNAL OF HETEROCYCLIC CHEMISTRY

Volume: 52

Issue: 2

Page: 425-439

DOI: 10.1002/jhet.2063

Published: 2015

6

ANTIRADICAL ACTIVITY OF L-GLUTAMINE, L-ASPARAGINE AND L-ASPARTIC ACID DERIVED REDUCED SCHIFF BASE COPPER(II) COMPLEXES

Authors: Lintnerova, L, Valentova, JDevinsky, F 

Journal: STUDIA UNIVERSITATIS BABES-BOLYAI CHEMIA

Volume: 61

Issue: 4

Page: 85-98

Published: 2016

7

The design and NMR structure determination of yttrium-oligopeptide tags for recombinant proteins and antibodies

Authors: Mudra, MBreza, M, Lintnerova, L, Filo, J, Bauer, J 

Journal: ACTA CHIMICA SLOVACA

Volume: 11

Issue: 2

Page: 120-133

DOI: 10.2478/acs-2018-0018

Published: 2018

8

Chirality in Anticancer Agents

Authors: Valentová, J., Lintnerová, L.

Book: Current Topics in Chirality - From Chemistry to Biology

Online: https://www.intechopen.com/chapters/77627

DOI: 10.5772/intechopen.98977

Publishes: 2020

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Chiral ligand induced geometrical type of isomerism in Schiff-base Copper (II) complexes with urease inhibitory activities

Authors: Valentová, J., Lintnerová, L., Sláviková, B., Baran, P.

Journal: Inorganica Chimica Acta

Volume: 558

paged: 1-8

article number: 121707 [online]

DOI: 10.1016/j.ica.2023.121707

Published: 2023

2

Analogues of Anticancer Natural Products: Chiral Aspects

Autori: Valentová, J., Lintnerová, L., Miklášová, N., Oboňová, B., Habala, L.

Časopis: International journal of molecular sciences [elektronický dokument]

Ročník: 24

číslo: 6

strany: 1-23

číslo článku: 5679 [online]

DOI: 10.3390/ijms24065679

Publikované: 2023

3

Chirality in Anticancer Agents

Authors: Valentová, J., Lintnerová, L.

Book: Current Topics in Chirality - From Chemistry to Biology

Online: https://www.intechopen.com/chapters/77627

DOI: 10.5772/intechopen.98977

Publishes: 2020

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Synthesis, biological evaluation, and molecular docking of new series of antitumor and apoptosis inducers designed as VEGFR-2 inhibitors

Authors: Abdallah, AE; Mabrouk, RR; Al Ward, MMS; Eissa, SI; Elkaeed, EB; Mehany, ABM; Abo-Saif, MA; El-Feky, OA; Alesawy, MS; El-Zahabi, MA

Journal: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Published: 2022

Volume: 37

Pages: 573-591

DOI: 10.1080/14756366.2021.2017911

2

Design, synthesis, and anti-proliferative evaluation of new quinazolin-4 (3H)-ones as potential VEGFR-2 inhibitors

Authors: El-Adl, K; El-Helby, AGA; Ayyad, RR; Mahdy, HA; Khalifa, MM; Elnagar, HA; Mehany, ABM; Metwaly, AM; Elhendawy, MA; Radwan, MM; ElSohly, MA; Eissa, IH

Journal: BIOORGANIC & MEDICINAL CHEMISTRY

Published: 2021

Volume: 29

Article number: 115872

DOI: 10.1016/j.bmc.2020.115872

3

Cu(II) and V(IV)O complexes with tri- or tetradentate ligands based on (2-hydroxybenzyl)-L-alanines reveal promising anticancer therapeutic potential

Authors: Ribeiro, N; Bulut, I; Cevatemre, B; Teixeira, C; Yildizhan, Y; Andre, V; Adao, P; Pessoa, JC; Acilan, C; Correia, I

Journal: DALTON TRANSACTIONS

Published: 2021

Volume: 50

Pages: 157-169

DOI: 10.1039/d0dt03331f

4

Discovery of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation

Authors: Eissa, IH; El-Helby, AGA; Mahdy, HA; Khalifa, MM; Elnagar, HA; Mehany, ABM; Metwaly, AM; Elhendawy, MA; Radwan, MM; ElSohly, MA; El-Adl, K

Journal: BIOORGANIC CHEMISTRY

Published: 2020

Volume: 105

Article number: 104380

DOI: 10.1016/j.bioorg.2020.104380

5

Current Scenario of 1,3-oxazole Derivatives for Anticancer Activity

Authors: Yan, XJ; Wen, J; Zhou, L; Fan, L; Wang, XB; Xu, Z

Journal: CURRENT TOPICS IN MEDICINAL CHEMISTRY

Published: 2020

Volume: 20

Pages: 1916-1937

DOI: 10.2174/1568026620666200624161151

6

Equilibria in Aqueous Cobalt(II)-Reduced Schiff BaseN-(2-hydroxybenzyl)alanine System: Chemical Characterization, Kinetic Analysis, Antimicrobial and Cytotoxic Properties

Authors: Wozniczka, M; Sutradhar, M; Pombeiro, AJL; Swiatek, M; Pajak, M; Gadek-Sobczynska, J; Chmiela, M; Gonciarz, W; Pasternak, B; Kufelnicki, A

Journal: MOLECULES

Published: 2020

Volume: 25

Article number: 3462

DOI: 10.3390/molecules25153462

7

Oxazole-Based Compounds As Anticancer Agents

Authors: Chiacchio, MA; Lanza, G; Chiacchio, U; Giofre, SV; Romeo, R; Iannazzo, D; Legnani, L

Journal: CURRENT MEDICINAL CHEMISTRY

Published: 2019

Volume: 26

Pages: 7337-7371

DOI: 10.2174/0929867326666181203130402

8

Recent advance in oxazole-based medicinal chemistry

Authors: Zhang, HZ; Zhao, ZL; Zhou, CH

Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Published: 2018

Volume: 144

Pages: 444-492

DOI: 10.1016/j.ejmech.2017.12.044

9

Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs

Authors: Zhang, J; Jiang, XD; Jiang, YN; Guo, MR; Zhang, SY; Li, JJ; He, J; Liu, J; Wang, JH; Ouyang, L

Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Published: 2016

Volume: 108

Pages: 495-504

DOI: 10.1016/j.ejmech.2015.12.016

10

Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl) phthalazine derivatives

Authors: Eldehna, WM; Abou-Seri, SM; El Kerdawy, AM; Ayyad, RR; Hamdy, AM; Ghabbour, HA; Ali, MM; Abou El Ella, DA

Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Published: 2016

Volume: 113

Pages: 50-62

DOI: 10.1016/j.ejmech.2016.02.029

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

Project number: UK/34/2010

Project leader: Mgr. Lucia Lintnerová, PhD.

Project title: Synthesis and testing of novel inhibitors of tumor neovascularization with VEGFR-2 receptor selectivity

2

Project number: FAF/4/2014

Project leader: Mgr. Lucia Lintnerová, PhD.

Project title: Synthesis of ligands of copper(II) complexes with antiradical activity

3

Project number: FAF/9/2015

Project leader: Mgr. Lucia Lintnerová, PhD.

Project title: Synthesis and study of copper(II) complexes prepared from reduced Schiff bases as ligands

4

Project number: FAF/11/2016

Project leader: Mgr. Lucia Lintnerová, PhD.

Project title: Strudy of antiradical activity and spectral properties of copper(II) complexes prepared from reduced Schiff bases as ligands

5

Project number: APVV-0516-12

Project leader: Dr.h.c. prof. Ing. Ferdinand Devínsky, DrSc.

Project title: Small molecules in biomedical research

6

Project number: VEGA 1/0346/16

Project leader: doc. PharmDr. Valentová Jindra, PhD.

Project title: Chiral drugs - stereospecific aspects of biological activity, metabolism and biological availability

7

Project number:VEGA 1/0145/20

Project leader: doc. PharmDr. Valentová Jindra, PhD.

Project title: New antineoplastics based on metalocomplexes and with mitochondria aimed activity

8

Project number: APVV-23-0349

Project leader: doc. Ing. Martin Pisárčik, CSc.

Project title: Optimalized composite gold and silver nanoparticles for biomedical applications

9

Project number: VEGA 1/0661/24

Project leader: doc. PharmDr. Valentová Jindra, PhD.

Project title: New type of metallopharmaceuticals with cytostatic effect targeting mitochondria and DNA

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position VII.b - Name of the institution, board VII.c - Duration
department secretary Department of chemical theory of drugs, Faculty of Pharmacy, Comenius Univerzity in Bratislava 1.9.2017 - present
department teaching schedule administrator Department of chemical theory of drugs, Faculty of Pharmacy, Comenius Univerzity in Bratislava 1.9.2017 - present
head of synthetic laboratory Department of chemical theory of drugs, Faculty of Pharmacy, Comenius Univerzity in Bratislava 1.9.2015 - present
head of laboratory and classroom of molecular modeling Department of chemical theory of drugs, Faculty of Pharmacy, Comenius Univerzity in Bratislava 1.9.2015 - present

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution VIII.b - Address of the institution VIII.c - Duration (indicate the duration of stay) VIII.d - Mobility scheme, employment contract, other (describe)
University of Regensburg, Department of Organic Chemistry Universitätsstraße 31, 93053 Regensburg, Germany 1.4.2008 - 31.7.2008 Erasmus/Socrates program, contact: Prof. Dr. Burkhard König, education and research mobility

IX. - Other relevant facts

IX.a - If relevant, other activities related to higher education or research/artistic/other activities are mentioned

Skriptum for english program of Pharmacy for the subject Generanl and Inorganic Chemistry:

https://stella.uniba.sk/texty/FAF_inorganic_chem_laboratory_work_calculations.pdf



Skriptum for english program of Pharmacy for the subject Organic Chemistry 1: https://stella.uniba.sk/texty/FAF_NMLHLL_Laboratory_Techniques_Syntheses_Organic_Chemistry.pdf

Date of last update
2025-01-29